Rheumatoid Arthritis Drugs Market

Rheumatoid Arthritis Drugs Market Size Survey Report – In a Glance

As per the survey report on global Rheumatoid Arthritis Drugs market, the market is projected to foresee a CAGR of 6.2% between 2024-2033, and further generate a market size of USD 115.7 revenue billion by the end of 2033. In the year 2024, the market size was valued at USD 57.5 revenue billion.

• The global Rheumatoid Arthritis Drugs market is projected to grow on account of the high prevalence of arthritis.
• In Japan, the Rheumatoid Arthritis Drugs market growth can be attributed to the expanding senior population.
• KDMI analyst’s growth analysis foresees high cost of pharmaceuticals to challenge the market growth.
• North America, having the highest market share in the Rheumatoid Arthritis Drugs market, is projected to dominate the global market.

Rheumatoid Arthritis Drugs Market Analysis

Rheumatoid arthritis is a chronic auto-immune inflammatory disorder where the body’s immune system doesn’t work properly and erroneously attacks its tissue, including the joints, causing pain, swelling, inflammation, and rigidity instead of foreign invaders. It has been observed that more than 350 million people have arthritis worldwide. In the U.S., 1 in 4 adults was diagnosed with arthritis in 2020 and it is expected to be 78 million by the year 2040. As per findings, in 2020, 17.6 million people are living with rheumatoid arthritis across the globe and it was found that the occurrence of rheumatoid arthritis is higher in females than males. Bayer AG (Germany), Casper Pharma (U.S.), Dr. Reddy's Laboratories Ltd. are some of the significant parties in the global market for Rheumatoid Arthritis Drugs.

Analyst’s Observation on Japan Rheumatoid Arthritis Drugs Market Survey

In Japan, the market growth for Rheumatoid Arthritis Drugs can be attributed to the expanding senior population in the country. As per the World Bank Group data, the percentage of the overall population falling in the age group 65 and up has expanded rapidly and is a key growth driver of the market. There were near about more than 245 million people in the age group 65 years and above living in the Western Pacific region. It is likely to rise to around 458 million by 2040 and the fraction of the region's population over 65 years will almost double from 12% to 23%, over the next twenty years. Janssen Pharmaceuticals K.K., Taisho Pharmaceutical Group, Toyama Chemical Co. Ltd are some of the significant parties in the market for Rheumatoid Arthritis Drugs in Japan.

Rheumatoid Arthritis Drugs Market Growth Driver

Growing development in biologics:

In the market, there exists a variety of different combinations of biologics for RA (Rheumatoid Arthritis) treatment. Biologics are healthcare products that are produced in the cells of living organisms and are used to treat various diseases like auto-immune disorders or cancers, which include vaccines, growth factors, monoclonal antibodies, and immune modulators. As stated by the Arthritis Foundation, biologics like Belimumab are approved by the FDA for lupus and lupus nephritis in adults and children aged 5 to 17 and  Abatacept may contribute to bettering interstitial lung disease which is a critical complication affecting up to 50% of people with RA (Rheumatoid Arthritis).

Rheumatoid Arthritis Drugs Market Segmentation

Our experts at KD Market Insights have segmented the global Rheumatoid Arthritis Drugs market research report as:

Rheumatoid Arthritis Drugs Market Regional Synopsis

North America, having the highest market share in the Rheumatoid Arthritis Drugs market is majorly driven by multiple factors such as the surging prevalence of rheumatoid arthritis, the strong market influence of the major market players, the rising launch of biologics such as monoclonal antibodies for rheumatoid arthritis, and rising investments from the market players for the progress of cutting-edge therapies and innovations for this disease are expected to drive the market growth in the region.

As per our analysts at KD Market Insights, the following five players lead the North America Rheumatoid Arthritis Drugs market growth:

• Merck & Co. Inc.
• Amgen Inc.
• Novartis AG
• Sanofi
• Pfizer Inc.

Rheumatoid Arthritis Drugs Market Competitive Landscape

Some of the key players who top the global Rheumatoid Arthritis Drugs market share:

• Pfizer Inc. (U.S.)
• Abbvie Inc. (U.S.)
• Novartis AG (Switzerland)
• Amgen Inc. (U.S.)
• Merck & Co Inc. (U.S.)
• Teva Pharmaceuticals Industries Ltd. (Israel)
• AstraZeneca (U.K.)
• Ampio Pharmaceuticals Inc. (U.S.)
• Bayer AG (Germany)
• Casper Pharma (U.S.)
• Dr. Reddy's Laboratories Ltd. (India)

1. Executive Summary
   1. Market Overview
   2. Key Findings
   3. Market Trends
   4. Market Outlook
2. Introduction
   1. Scope of the Report
   2. Research Methodology
   3. Definitions and Assumptions
   4. Acronyms and Abbreviations
3. Market Dynamics
   1. Drivers
   2. Restraints
   3. Opportunities
   4. Challenges
4. Global Rheumatoid Arthritis Drugs Market
   1. Market Overview
   2. Market Size and Forecast
   3. Market Segmentation
      1. By Drug type
      2. By Route of administration
      3. By Distribution channels
      4. By Therapy
      5. By End-user
      6.  By Region
5. Market Segmentation by Drug type
   1. 1. Pharmaceuticals
      2. NSAIDs
      3. Analgesics
      4. DMARDs
      5. Glucocorticoids
      6. Biopharmaceuticals
      7. Biologics
      8. Biosimilars
6. Market Segmentation by Route of administration
   1. 1. Oral
      2. Parenteral
      3. Topical
      4. Others
7. Market Segmentation by Distribution channels
   1. 1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Drug Stores
8. Market Segmentation by Therapy
   1. 1. Symptomatic Treatment
      2. Intermediate Corticosteroid Therapies
      3. Stem Cell Therapy/ Cell Therapy
      4. Disease Modifying Anti-rheumatic Drug (DMARD)
      5. Conventional DMARDs
      6. Biological DMARDs
9. Market Segmentation by End-user
   1. 1. Hospitals
      2. Specialty Clinics
      3. Others
10. Regional Analysis
    1. North America
       1. United States
          1. Market Size and Forecast
          2. Key Trends and Developments
          3. Market Analysis by Drug type, Route of administration, Distribution channels, Therapy, End-user
       2. Canada
          1. Market Size and Forecast
          2. Key Trends and Developments
          3. Market Analysis by Drug type, Route of administration, Distribution channels, Therapy, End-user
          4.  
       3. Mexico
          1. Market Size and Forecast
          2. Key Trends and Developments
          3. Market Analysis by Drug type, Route of administration, Distribution channels, Therapy, End-user
    2. Europe
       1. United Kingdom
          1. Market Size and Forecast
          2. Key Trends and Developments
          3. Market Analysis by Drug type, Route of administration, Distribution channels, Therapy, End-user
          4.  
       2. Germany
          1. Market Size and Forecast
          2. Key Trends and Developments
          3. Market Analysis by Drug type, Route of administration, Distribution channels, Therapy, End-user
       3. France
          1. Market Size and Forecast
          2. Key Trends and Developments
          3. Market Analysis by Drug type, Route of administration, Distribution channels, Therapy, End-user
          4.  
       4. Italy
          1. Market Size and Forecast
          2. Key Trends and Developments
          3. Market Analysis by Drug type, Route of administration, Distribution channels, Therapy, End-user
          4.  
       5. Spain
          1. Market Size and Forecast
          2. Key Trends and Developments
          3. Market Analysis by Drug type, Route of administration, Distribution channels, Therapy, End-user
          4.  
       6. Rest of Europe
          1. Market Size and Forecast
          2. Key Trends and Developments
          3. Market Analysis by Drug type, Route of administration, Distribution channels, Therapy, End-user
          4.  
    3. Asia Pacific
       1. China
          1. Market Size and Forecast
          2. Key Trends and Developments
          3. Market Analysis by Drug type, Route of administration, Distribution channels, Therapy, End-user
          4.  
       2. Japan
          1. Market Size and Forecast
          2. Key Trends and Developments
          3. Market Analysis by Drug type, Route of administration, Distribution channels, Therapy, End-user
          4.  
       3. India
          1. Market Size and Forecast
          2. Key Trends and Developments
          3. Market Analysis by Drug type, Route of administration, Distribution channels, Therapy, End-user
          4.  
       4. Australia
          1. Market Size and Forecast
          2. Key Trends and Developments
          3. Market Analysis by Drug type, Route of administration, Distribution channels, Therapy, End-user
          4. South Korea
          5. Market Size and Forecast
          6. Key Trends and Developments
          7. Market Analysis by Drug type, Route of administration, Distribution channels, Therapy, End-user
          8.  
       5. Rest of Asia Pacific
          1. Market Size and Forecast
          2. Key Trends and Developments
          3. Market Analysis by Drug type, Route of administration, Distribution channels, Therapy, End-user
          4.  
    4. Latin America
       1. Brazil
          1. Market Size and Forecast
          2. Key Trends and Developments
          3. Market Analysis by Drug type, Route of administration, Distribution channels, Therapy, End-user
          4.  
       2. Argentina
          1. Market Size and Forecast
          2. Key Trends and Developments
          3. Market Analysis by Drug type, Route of administration, Distribution channels, Therapy, End-user
          4.  
       3. Colombia
          1. Market Size and Forecast
          2. Key Trends and Developments
          3. Market Analysis by Drug type, Route of administration, Distribution channels, Therapy, End-user
          4.  
       4. Rest of Latin America
          1. Market Size and Forecast
          2. Key Trends and Developments
          3. Market Analysis by Drug type, Route of administration, Distribution channels, Therapy, End-user
          4.  
    5. Middle East & Africa
       1. South Africa
          1. Market Size and Forecast
          2. Key Trends and Developments
          3. Market Analysis by Drug type, Route of administration, Distribution channels, Therapy, End-user
          4.  
       2. Saudi Arabia
          1. Market Size and Forecast
          2. Key Trends and Developments
          3. Market Analysis by Drug type, Route of administration, Distribution channels, Therapy, End-user
          4.  
       3. UAE
          1. Market Size and Forecast
          2. Key Trends and Developments
          3. Market Analysis by Drug type, Route of administration, Distribution channels, Therapy, End-user
          4.  
       4. Rest of Middle East & Africa
          1. Market Size and Forecast
          2. Key Trends and Developments
          3. Market Analysis by Drug type, Route of administration, Distribution channels, Therapy, End-user
          4.  
11. Competitive Landscape
    1. Market Share Analysis
    2. Company Profiles
    3. Medtronic (Ireland)
    4. IBM
    5. Apple Inc.
    6. Siemens Medical Solutions
    7. Pepperl+Fuchs
    8. Cisco
    9. GE Healthcare
12. Strategic Recommendations
13. Appendix
    1. List of Tables
    2. List of Figures
14. References